Sign In
Buy GSK
$51.53
+0.0200 (+0.0388%)
At Close: Aug 04, 2026
GSK splashes out $1.2bn up-front for liver treatment still in clinical trials
02:55am, Wednesday, 14'th May 2025
GSK PLC (LSE:GSK, NYSE:GSK) has struck a deal to acquire a drug to treat and prevent the progression of steatotic liver disease, poised for phase III clinical trials, for up to $2 billion. The disea
GSK Buys Liver-Disease Treatment From Boston Pharmaceuticals for Up to $2 Billion
02:42am, Wednesday, 14'th May 2025
The pharma giant will pay $1.2 billion up-front for efimosfermin, with deal including potential success-based milestone payments of $800 million.
GSK to buy efimosfermin for up to $2 billion
02:24am, Wednesday, 14'th May 2025
British pharmaceutical giant GSK on Wednesday said it will buy efimosfermin, a phase III-ready potential specialty medicine from Boston Pharmaceuticals, for up to $2 billion.
CAMBRIDGE, Mass.--(BUSINESS WIRE)--GSK plc (LSE/NYSE: GSK) and Boston Pharmaceuticals, a leading clinical stage biopharmaceutical company developing highly targeted therapies for patients with serious
ITeos, GSK discontinue lung cancer therapy development
08:21am, Tuesday, 13'th May 2025
iTeos Therapeutics and partner GSK said on Tuesday that they terminated the development of their experimental lung cancer therapy after its failure to significantly improve progression free survival i
India's GlaxoSmithKline Pharma reports profit rise on strong demand
07:45am, Tuesday, 13'th May 2025
India's GlaxoSmithKline Pharmaceuticals reported a higher fourth-quarter profit on Tuesday, led by steady demand for its generic drugs.
Glaxo (GSK) Upgraded to Buy: Here's What You Should Know
01:05pm, Monday, 12'th May 2025
Glaxo (GSK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Dr. Scott Gottlieb: What to expect from President Trump's executive order to lower drug prices
12:36pm, Monday, 12'th May 2025
Scott Gottlieb, former FDA commissioner, joins CNBC's 'Squawk on the Street' to discuss how the White House may plan to cut drug prices.
GSK and Lifetime® launch original movie to raise awareness about the impact of meningitis
09:00am, Friday, 09'th May 2025
PHILADELPHIA--(BUSINESS WIRE)-- #Adolescents--GSK and Lifetime® launch original movie to raise awareness about the impact of meningitis.
GSK price target lowered to 1,355 GBp from 1,450 GBp at Morgan Stanley
01:23pm, Wednesday, 07'th May 2025
Morgan Stanley lowered the firm's price target on GSK to 1,355 GBp from 1,450 GBp and keeps an Underweight rating on the shares.
5 Reasons GSK Looks Good
11:37am, Monday, 05'th May 2025
GSK's stock price has significantly outperformed the healthcare sector this year, supported by its healthy Q1 2025 numbers. Both turnover and EPS growth exceeded expectations, and the company's guidan
Here's Why GSK (GSK) is a Strong Growth Stock
10:46am, Thursday, 01'st May 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
GSK Q1 Earnings Beat, Sales Lag, Stock Gains on Tariff Reassurance
12:46pm, Wednesday, 30'th Apr 2025
GSK reports mixed first-quarter 2025 results. Shares rise in pre-market after it reaffirms guidance and says it is "well positioned" to handle the U.S. tariffs.
GSK plc (GSK) Q1 2025 Earnings Conference Call Transcript
12:32pm, Wednesday, 30'th Apr 2025
GSK plc (NYSE:GSK ) Q1 2025 Earnings Conference Call April 30, 2025 7:00 AM ET Company Participants Constantin Fest - Head of IR Emma Walmsley - CEO Luke Miels - Chief Commercial Officer Julie Brown -
Here's Why GSK (GSK) is a Strong Momentum Stock
10:55am, Wednesday, 30'th Apr 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
